These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6813323)

  • 1. Studies on FAD- and FMN-binding domains in NADPH-cytochrome P-450 reductase from rabbit liver microsomes.
    Nisimoto Y; Shibata Y
    J Biol Chem; 1982 Nov; 257(21):12532-9. PubMed ID: 6813323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Location of functional -SH groups in NADPH-cytochrome P-450 reductase from rabbit liver microsomes.
    Nisimoto Y; Shibata Y
    Biochim Biophys Acta; 1981 Dec; 662(2):291-9. PubMed ID: 6797474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase.
    Vermilion JL; Ballou DP; Massey V; Coon MJ
    J Biol Chem; 1981 Jan; 256(1):266-77. PubMed ID: 6778861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 31P-nuclear-magnetic-resonance study of NADPH-cytochrome-P-450 reductase and of the Azotobacter flavodoxin/ferredoxin-NADP+ reductase complex.
    Bonants PJ; Müller F; Vervoort J; Edmondson DE
    Eur J Biochem; 1990 Jul; 190(3):531-7. PubMed ID: 2115440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH-cytochrome P-450 reductase. Physical properties and redox behavior in the absence of the FAD moiety.
    Kurzban GP; Howarth J; Palmer G; Strobel HW
    J Biol Chem; 1990 Jul; 265(21):12272-9. PubMed ID: 2115516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH.
    Oprian DD; Coon MJ
    J Biol Chem; 1982 Aug; 257(15):8935-44. PubMed ID: 6807985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blue light mediated photoreduction of the flavoprotein NADPH-cytochrome P450 reductase. A Förster-type energy transfer.
    Müller-Enoch D
    Z Naturforsch C J Biosci; 1997; 52(9-10):605-14. PubMed ID: 9373993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavins of NADPH-cytochrome P-450 reductase: evidence for structural alteration of flavins in their one-electron-reduced semiquinone states from resonance Raman spectroscopy.
    Sugiyama T; Nisimoto Y; Mason HS; Loehr TM
    Biochemistry; 1985 Jun; 24(12):3012-9. PubMed ID: 3925989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the oxidation of hydroxyl radical scavenging agents after alkaline phosphatase treatment of rat liver microsomes.
    Puntarulo S; Cederbaum AI
    Biochim Biophys Acta; 1991 May; 1074(1):12-8. PubMed ID: 1904277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the microsomal mixed-function oxidase system: mechanism of action of hepatic NADPH-cytochrome P-450 reductase.
    Iyanagi T; Makino R; Anan FK
    Biochemistry; 1981 Mar; 20(7):1722-30. PubMed ID: 6784758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FMN-binding domain of cytochrome P450BM-3: resolution, reconstitution, and flavin analogue substitution.
    Haines DC; Sevrioukova IF; Peterson JA
    Biochemistry; 2000 Aug; 39(31):9419-29. PubMed ID: 10924137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dissociation of flavin coenzymes from trypsin-solubilized NADPH/Cytochrome c (P-450) reductase of pig-liver microsomes.
    Trout GE
    Eur J Biochem; 1976 Dec; 71(2):533-7. PubMed ID: 12969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of FAD-dependent NADPH-cytochrome P-450 reductase.
    Kurzban GP; Strobel HW
    J Biol Chem; 1986 Jun; 261(17):7824-30. PubMed ID: 3086319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains.
    Sevrioukova I; Truan G; Peterson JA
    Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.
    Gutierrez A; Lian LY; Wolf CR; Scrutton NS; Roberts GC
    Biochemistry; 2001 Feb; 40(7):1964-75. PubMed ID: 11329263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of FAD-dependent cytochrome P450 reductase activity by photoreduction.
    Hodgson AV; Strobel HW
    Anal Biochem; 1996 Dec; 243(1):154-7. PubMed ID: 8954538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between changes in properties and contents of riboflavin derivatives of NADPH-cytochrome P-450 reductase in the liver microsomes of riboflavin-deficient rats.
    Hara T; Taniguchi M
    J Biochem; 1985 Feb; 97(2):473-82. PubMed ID: 3924902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
    Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
    Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation activity mediated by NADPH-cytochrome C reductase purified from rabbit liver microsomes.
    Kamataki T; Naminohira S; Sugita O; Kitagawa H
    Jpn J Pharmacol; 1978 Dec; 28(6):819-27. PubMed ID: 218031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a phosphorothioate analogue of flavin mononucleotide: reconstitution of the FMN-free form of NADPH-cytochrome P-450 reductase.
    Calhoun JP; Miziorko HM; Otvos JD; Krum DP; Ugent S; Masters BS
    Biochemistry; 1987 Aug; 26(17):5344-50. PubMed ID: 3118943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.